The short answer
TB-500 is Ac-Leu-Lys-Lys-Thr-Glu-Thr-Gln, seven residues taken from positions 17 to 23 of thymosin beta-4 with an acetylated N-terminus. At 889.0 Da it is small, highly polar, and carries no cysteine, methionine or aromatic residue.
Key facts
- Sequence
- Ac-LKKTETQ
- Residues
- 7
- Molecular weight
- 889.0 Da
- Formula
- C38H68N10O14
- Origin
- Residues 17-23 of thymosin beta-4
- N-terminus
- Acetylated (+42.0 Da)
- Cys / Met / aromatic
- None of any
An internal fragment, not a terminal one
TB-500 comes from the middle of its parent, which is unusual among research peptides. Most fragments in circulation are N-terminal or C-terminal pieces. Taking an internal segment means both ends are artificial: the natural sequence continues in both directions in the parent, and the fragment's termini exist only because synthesis stopped there.
Why the N-terminus is acetylated
An internal residue has no free alpha-amino group. It is engaged in a peptide bond with the residue before it. Synthesising the fragment alone creates a free amine that does not exist in the protein, carrying a positive charge that is an artefact of the excision. Acetylation caps it, restoring something closer to the parent's electrostatics and incidentally slowing aminopeptidase attack.
Research material referenced
TB-500 5mg, third-party HPLC tested
The composition
Two lysines, one glutamate, two threonines, one leucine, one glutamine. Strongly polar throughout with no hydrophobic core, and net positively charged at physiological pH. There is no cysteine, no methionine and no aromatic residue, which removes disulfide chemistry, methionine oxidation, and the possibility of quantification by absorbance at 280 nm respectively.
What the structure implies
A short, highly charged, aromatic-free peptide will be very water-soluble and conformationally flexible. It will adsorb readily to surfaces, which matters for small quantities. And it offers no convenient spectroscopic handle, so concentration must be established by other means.
How the parent differs
Thymosin beta-4 at 43 residues contains methionine and other residues absent from the fragment, and behaves quite differently in handling as well as biology. Guidance written for one does not automatically apply to the other, which is a recurring theme in this category and a direct consequence of two products sharing a name.
Frequently asked questions
Is TB-500 an N-terminal fragment?
No. It is internal, from residues 17 to 23. Both its termini are artefacts of synthesis rather than features of the parent.
Why does acetylation matter?
It caps a free amine that does not exist in the protein, restoring closer electrostatics and slowing aminopeptidase degradation.
Can TB-500 be quantified at 280 nm?
No. There is no tryptophan, tyrosine or phenylalanine, so it has no usable absorbance there.
Continue researching
Peer-reviewed guides, comparators and matched reference materials.
Primary sources & clinical trials
Peer-reviewed research and registered trials from PubMed, ClinicalTrials.gov, PubChem, FDA and NIH. All links open in a new tab and point to the primary source, so every claim can be verified at origin.
- PubChemPubChem · TB-500 (CID 62707662)pubchem.ncbi.nlm.nih.gov
- PubChemPubChem · LKKTETQ (CID 10169788)pubchem.ncbi.nlm.nih.gov
- PubMedLow TL et al., Complete amino acid sequence of bovine thymosin beta 4. PNAS 1981 (PMID 6940133)pubmed.ncbi.nlm.nih.gov
- PubMedGoldstein AL et al., Thymosin β4: a multi-functional regenerative peptide. Expert Opin Biol Ther 2012 (PMID 22074294)pubmed.ncbi.nlm.nih.gov
- PubMedShrivastava S et al., Thymosin beta4 and cardiac repair. Ann N Y Acad Sci 2010 (PMID 20536454)pubmed.ncbi.nlm.nih.gov
- PubMedSosne G et al., Thymosin beta 4 promotes corneal wound healing. Exp Eye Res 2002 (PMID 11950239)pubmed.ncbi.nlm.nih.gov
- TrialClinicalTrials.gov · Thymosin β4 (RGN-259) dry eye Phase 3 (NCT03925727)clinicaltrials.gov
- PubChemPubChem · Thymosin β4 (CID 16132341)pubchem.ncbi.nlm.nih.gov
- GuidelineGoogle: Creating helpful, reliable, people-first contentdevelopers.google.com
Browse the wider literature
Live database searches, not fixed citations. Results change as new work is indexed.
Written and reviewed by
William Heath · Editor, UK Peptides research library
William Heath edits the UK Peptides research library. He is responsible for what is published here: every article is sourced to primary literature, every purity or identity statement traces to a signed third-party certificate for a specific lot, and corrections are made in place with the review date updated. No scientific or medical credentials are claimed on this site; the evidence is carried by the cited sources and the certificates, not by the byline.
More TB-500 (Thymosin β4 fragment) articles
- TB-500 Molecular Structure and Physical Properties889.0 Da, C38H68N10O14, no cysteine or methionine, no aromatic residue. The physical consequences of a short, highly charged, flexible peptide.
- TB-500 Storage, Stability and ReconstitutionNo cysteine, methionine or asparagine, so the usual degradation routes do not apply. Adsorption to surfaces is the loss mechanism that actually matters.
- TB-500 Half-Life and ClearanceA seven-residue peptide with no half-life extension carries no protection against renal filtration or peptidases. Why acetylation helps only at one end.
- Cell Migration: What the Studies ReportMigration requires continual actin remodelling, which gives a sequestering protein a plausible route to affect it. What the assays measure and what they do not.
- Angiogenesis: What the Literature ReportsNew vessel formation requires endothelial cells to migrate, which connects it to actin biology. What the models show and why the mechanism is less direct here.